PPT-European strategic action plan on antibiotic resistance

2011 2020 amp Global action plan on AMR 2015 Dr Danilo Lo Fo Wong Programme Manager AMR WHO Regional Office for Europe WHO efforts on antimicrobial resistance 2014 2015 2001 2003. . usage. . and. . resistance. . unavoidable. link?. Evelina Tacconelli. Comprehensive. Center . for. . Infectious. . Diseases. DZIF Partner Center . Tübingen University. Germany. Antimicrobial Resistance: How to Foster Innovation, Access . Health Plans Address the Challenge of. Antibiotic Resistance. Robert Scalettar, M.D.. July 19, 2005. An Introduction to CAQH. The Council for Affordable Quality Healthcare (CAQH) is a not-for-profit alliance of health plans and networks that promotes collaborative initiatives to:. the Continued Evolution of Antimicrobial Resistance. Bert K. . Lopansri. , MD. Division of Infectious Diseases and Clinical Epidemiology. Associate Professor, University of Utah. Medical Director, Intermountain Central Laboratory. Overview. Discuss antibiotic resistance in the United States . Summarize recent national policy developments. Describe . the Get Smart: Know When Antibiotics Work program. Discuss perceptions/misperceptions contributing to . and bacteria. Gail R. Hansen, DVM, MPH. Senior Officer. Pew Human Health and Industrial Farming. The problem. Antimicrobial resistance is one of the most significant challenges facing modern public . Jennifer Ott, PharmD, BCPS. Clinical Pharmacy Specialist, Infectious Diseases. Eastern Maine Medical Center. Bangor, ME. jott@emh.org. The use of antibiotics is the single most important factor leading to antibiotic resistance. June 1, 2017. Courtney . Holzheimer. , DNP, FNP-BC. Sara Lee, MD. Courtney . Holzheimer. , . DNP, . FNP-BC. Nurse Practitioner, Case Western Reserve University . Sara Lee, MD. Adolescent Medicine, Rainbow Babies and Children’s . . resistance. . unavoidable. link?. Evelina Tacconelli. Comprehensive. Center . for. . Infectious. . Diseases. DZIF Partner Center . Tübingen University. Germany. Antimicrobial Resistance: How to Foster Innovation, Access . Photo: . Mycobacterium tuberculosis . bacteria, . NIAID . (from . flickr. ).. 1. Photo: . Staphylococcus . epidermidis. . bacteria, . NIAID . (from . flickr. ).. 2. By . ReAct. F. unding . from Marie-Claire . Komal. . Pareek. 1. Key Terms. Antibiotic = A drug that kills or inhibits the growth of microorganisms. Resistant = Somewhat arbitrary designation that implies that an antimicrobial will not inhibit bacterial growth at clinically achievable concentrations. Emily Lutterloh, MD, MPH. Director, Bureau of Healthcare Associated Infections. New York State Department of Health . Disclosures. Nothing to disclose. (grant support to New York State Department of Health through the federal Epidemiology and Laboratory Capacity Cooperative Agreement). in the United States, 2013 TABLE OF CONTENTS Foreword .............................................................................................. . Executive Summary .............................. Outline. History of antibiotics and types. Antibiotic resistances and MSRA . Methicillin-resistant . Staphylococcus aureus.  . Methodologies for detection. Case Studies. Conclusions. Antibiotics Have Transformed Human Medicine. Rupal Shah, . PharmD. . . 1. Objectives. Define antibiotic resistance and discuss the concerns associated with the increase of resistant strains. Review CDC guidelines and explore which patients may warrant antibiotic treatment..